Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Am J Health Syst Pharm ; 79(19): 1626-1633, 2022 09 22.
Article in English | MEDLINE | ID: covidwho-1890866

ABSTRACT

PURPOSE: To evaluate current evidence on the utility of hydrocortisone, ascorbic acid, and thiamine (HAT) therapy for the management of septic shock. SUMMARY: The following keyword search terms were utilized in PubMed to identify relevant articles: ascorbic acid, thiamine, hydrocortisone, shock, and critical care. Articles relevant to HAT therapy in patients with septic shock were selected. Retrospective cohorts and randomized controlled trials were included in this review; case reports/series were excluded. Data from included studies illustrating the use of HAT therapy for the management of sepsis and septic shock, including data on time to HAT therapy initiation, severity of illness at baseline, duration of vasopressor therapy, progression of organ failure, and mortality, were evaluated. CONCLUSION: The utilization of HAT therapy for the management of sepsis and septic shock remains controversial. Hemodynamic benefits have been shown to be most pronounced when HAT therapy is initiated earlier. Future studies directed at earlier initiation may be necessary to confirm this theory.


Subject(s)
Sepsis , Shock, Septic , Ascorbic Acid/therapeutic use , Drug Therapy, Combination , Humans , Hydrocortisone/therapeutic use , Retrospective Studies , Sepsis/drug therapy , Shock, Septic/drug therapy , Thiamine/adverse effects , Thiamine/therapeutic use
2.
Critical Care Medicine ; 50:456-456, 2022.
Article in English | Academic Search Complete | ID: covidwho-1592866

ABSTRACT

In patients with an arterial blood gas within 24 hours of iEPO initiation, there was no significant improvement in PaO SB 2 sb :FiO SB 2 sb ratio after iEPO initiation (127.3 ± 68.8 vs 138.9 ± 134.7;p=0.521). B Conclusions: b Initiation of iEPO in non-intubated ICU patients did not prevent intubation in 63.3% of patients. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

SELECTION OF CITATIONS
SEARCH DETAIL